Cardiovascular toxicity with clozapine: warning from Novartis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1322, 2002-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novartis Oncology have issued a letter alerting healthcare providers of new safety information, including a boxed warning, for Exjade

By  

Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cardiovascular toxicity of tyrosine kinase inhibitors

By Mouhayar Elie   Durand Jean-Bernard   Cortes Jorge  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Tricyclic Antidepressant Poisoning: Cardiovascular Toxicity

By Thanacoody H.K. Ruben   Thomas Simon H.L.  

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 24, Iss. 3, 2005-01 ,pp. : 205-214

Adis International

Access to resources Recommend Favorite

Clozapine: Drug toxicity with various neurological and respiratory symptoms in patients with acute infection: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1391, 2012-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Switch from brandname to generic clozapine pays dividends in the US

By  

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite